Universal Health Services

Q3 2026
Speakers

Oct 28, 2026 · 60 min

PREPARED REMARKS · INFERREDKeys: / search · Space play · ←→ ±10s · [] sections

Prepared remarks

Speaker 0

Unverified voice label

Good day and thank you for standing by. Welcome to the Q3 twenty twenty six Universal Health Services Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. ?

To
withdraw your question, please press star one one again. Please be advised that today's conference is being recorded. ?I would now to hand the conference over to your first speaker today, Darren Lehrich, Vice President of Investor Relations. Please go ahead.

Passages & reports (6)
  • Good day and thank you for standing by. Welcome to the Q3 twenty twenty six Universal Heal…
  • star one one on your telephone. You will then hear an automated message advising your hand…
  • To
  • withdraw your question, please press star one one again. Please be advised that today's co…
  • I would
  • now to hand the conference over to your first speaker today, Darren Lehrich, Vice Presiden…

Speaker 1

Unverified voice label

Good morning ?and welcome to Universal Health Services Third Quarter 2026 Earnings Conference Call. ?I'm Darren Larrick, Vice President of Investor Relations. With me this morning are our President and CEO, Mark Miller, and our Chief Financial Officer, Steve Filton. Mark and Steve will offer some remarks about the quarter and then we'll open up to QA. During today's conference call, we will be using words such as believes, expects, anticipates, estimates, and similar words that represent forecasts, projections, and forward looking statements.

For anyone not familiar with the risks and uncertainties inherent in these forward looking statements, we recommend a careful reading of the section on risk factors and forward looking statements and risk factors
?in our Form 10K for the year ended December 31st, 2025, ?and in our Form 10Q ?for the quarter ended June 30, 2026. In addition, we may reference measures during today's call, such as EBITDA, adjusted EBITDA, adjusted EBITDA, net of NCI, and adjusted net income attributable to UHS, which are non-GAAP financial measures.

Information and reconciliations of these non-GAP financial
measures to net income attributable to UHS can be found in yesterday's press release ?and in our supplemental materials on our website. With that, ?let me now turn it over to Mark for some introductory remarks.

Passages & reports (17)
  • Good morning
  • and
  • welcome to Universal Health Services Third Quarter 2026 Earnings Conference Call.
  • I'm
  • Darren Larrick, Vice President of Investor Relations. With me this morning are our Preside…
  • anticipates, estimates, and similar words that represent forecasts, projections, and forwa…
  • in
  • our Form 10K for the year ended December 31st, 2025,
  • and
  • in our Form 10Q
  • for
  • the quarter ended June 30, 2026. In addition, we may reference measures during today's cal…
  • measures to net income attributable to UHS can be found in yesterday's press release
  • and
  • in our supplemental materials on our website. With that,
  • let
  • me now turn it over to Mark for some introductory remarks.

Speaker 2

Unverified voice label

Thank you, Darren. Good morning, and thank you for joining today's call. ?I will begin with our key takeaways from the quarter performance relative to our expectations, the principal operating drivers, and progress on our strategic priorities before Steve reviews the detailed financial results and our outlook. Overall, underlying performance in the third quarter reflected sequential improvement in several areas. Acute care demand remained favorable.

Behavior health volumes demonstrated an increase relative to recent quarters, and labor trends continued to moderate. Expense management remained disciplined
overall. Health insurance exchange trends were consistent with our expectations. Steve will provide the reported financial results and segment metrics in his remarks. Third quarter results included certain items that were not reflected in the outlook we provided with our second quarter results in July.

These items included the benefit from the expansion of existing Medicaid supplemental programs in several states, partially offset by other non-recurring litigation and transaction costs, which Steve will take you through in
a ?moment. Against that backdrop, I want to highlight three operating and strategic priorities. Expanding acute care capacity and outpatient access points, integrating talkspace, and advancing the recertification process at Laurel Ridge Treatment Center in Texas.

First, our recent
investments in acute care inpatient capacity helped us meet favorable demand in our markets. The additional 177 beds added during the second quarter are expected to continue ramping through year ?end. We also expanded our outpatient portfolio by opening one freestanding emergency department in the third quarter and another FED that recently opened during the fourth quarter. In addition, our ambulatory development pipeline is expected to add several outpatient access points over the coming quarters.

The key takeaway is that these investments are performing well, broadening access and supporting growth. We expect their contribution to build over time as the new capacity matures. Second, in behavioral health, we completed the talkspace acquisition on August
17th and began executing the integration plan. We intend to discuss anticipated synergies in greater detail when we provide 2027 guidance in February. For the balance of 2026, we are taking a phased approach centered on three integration work streams.

The first deploying a technology platform and tools that enable smoother transitions of care and greater continuity of outpatient care for UHS patients. Number two, establishing referral flow processes to
talk space from UHS behavioral health and acute care facilities for both individual therapy and medication management services. And three, developing more flexible market-based outpatient offerings, initially emphasizing a virtual intensive outpatient program or IOP, offering designed to address strong demand in this area.

We expect these initiatives to support the acquisition's long-term benefits over the next 12 to 24 months. Our priorities are to expand access to outpatient mental health services and strengthen our outpatient
growth profile. The key takeaway is that our integration is underway, and the expected benefits will develop in phases as technology, new referral pathways, and service offerings are enhanced through our integration efforts.

We will provide further updates as the
integration progresses ?and the rollout expands across our operations. Third, at Laurel Ridge, our San Antonio team continues to work productively with regulatory authorities and the local community towards recertification, which we currently expect during 2027. The facility's third quarter financial impact was consistent with the assumptions in our updated July outlook. In closing, I want to thank the UHS team for its continued dedication to our mission to provide quality care.

Our strategy remains consistent, invest in attractive markets, expand access to
care, operate efficiently, and create long-term value for patients, employees, and shareholders. We remain mindful of execution requirements and the ever-evolving operating environment, and we believe the strength of our portfolio, the experience of our management team, and underlying demand in our markets continue to position us well over the long term. With that, I will turn the call over to Steve for additional detail on the quarter.

Passages & reports (24)
  • Thank you, Darren. Good morning, and thank you for joining today's call.
  • I
  • will begin with our key takeaways from the quarter performance relative to our expectation…
  • performance in the third quarter reflected sequential improvement in several areas. Acute …
  • overall. Health insurance exchange trends were consistent with our expectations. Steve wil…
  • provided with our second quarter results in July. These items included the benefit from th…
  • a
  • moment.
  • Against that backdrop, I want to highlight three operating and strategic priorities. Expan…
  • investments in acute care inpatient capacity helped us meet favorable demand in our market…
  • end.
  • We also expanded our outpatient portfolio by opening one freestanding emergency department…
  • coming quarters. The key takeaway is that these investments are performing well, broadenin…
  • 17th and began executing the integration plan. We intend to discuss anticipated synergies …
  • three integration work streams. The first deploying a technology platform and tools that e…
  • talk space from UHS behavioral health and acute care facilities for both individual therap…
  • offering designed to address strong demand in this area. We expect these initiatives to su…
  • growth profile. The key takeaway is that our integration is underway, and the expected ben…
  • integration progresses
  • and
  • the rollout expands across our operations. Third, at Laurel Ridge, our San Antonio team co…
  • financial impact was consistent with the assumptions in our updated July outlook. In closi…
  • care, operate efficiently, and create long-term value for patients, employees, and shareho…
  • in our markets continue to position us well over the long term. With that, I will turn the…

Speaker 1

Thanks, Mark. I will organize my remarks in four parts reported results and unusual items, segment performance, cash flow and capital allocation, and our 2026 outlook. Starting with reported results, the company reported adjusted EPS of $5.22 for the third quarter of 2026, representing a decline

Passages & reports (2)
  • Thanks, Mark. I will organize my remarks in four parts reported results and unusual items,…
  • 2026, representing a decline

Speaker unclear

?of

Passages & reports (1)
  • of

Speaker 3

Unverified voice label

8%

Passages & reports (1)
  • 8%

Speaker 1

year over year. Third quarter

Passages & reports (1)
  • year over year. Third quarter

Speaker unclear

?adjusted

Passages & reports (1)
  • adjusted

Speaker 3

EBITDA less NCI was $625 million as compared to $671 million

Passages & reports (1)
  • EBITDA less NCI was $625 million as compared to $671 million

Speaker unclear

?in

Passages & reports (1)
  • in

Speaker 1

the third quarter of 2025. The net out-of-period DPP headwind in the quarter was $37 million, when considering amounts recognized for the Washington, D.C. program approved in the third quarter of 2025, netted against out-of-period amounts recognized in this year's third quarter. To distinguish reported results from underlying performance in the third quarter of 2026, three specific items not contemplated in our annual adjusted EBITDALS NCI guidance provided in July produced a net favorable impact of $12 million.

These items were $47 million of supplemental Medicaid benefit
not included in our July forecast, $26 million of additional professional and general liability reserves primarily associated with the tentative settlement of a litigation matter related to our Cumberland facility in Virginia, and $8.5 million of transaction related costs

Passages & reports (3)
  • the third quarter of 2025. The net out-of-period DPP headwind in the quarter was $37 milli…
  • reported results from underlying performance in the third quarter of 2026, three specific …
  • not included in our July forecast, $26 million of additional professional and general liab…

Speaker 2

associated with the talkspace acquisition. Excluding these items,

Passages & reports (1)
  • associated with the talkspace acquisition. Excluding these items,

Speaker 1

adjusted EBITDA ?less NCI was below ?our internal expectations despite modest sequential improvement. ?The shortfall primarily reflected a slower than expected ramp up ?at our de novo hospitals and softer than expected surgical trends. Turning to segment performance, on a same facility basis, adjusted admissions at our acute care hospitals increased 4.9% compared with the third quarter of 2025. Volume performance was broad-based geographically and also benefited from capacity additions at three hospitals during the second quarter of 2026.

Same facility acute care emergency department visits increased 4.6%, while same facility surgeries decreased 0.7% compared with the third quarter of
2025. Inpatient and outpatient surgical cases declined at similar levels in the quarter. Inpatient medical admissions significantly outpaced surgical admissions, which negatively skewed pricing trends in the quarter. By service line, we experienced strength in cardiology, neurology, and urology similar to recent quarters. By payer class, adjusted admissions growth for Medicare and Managed Medicare was ?above the acute care segment average.

Volume growth for Medicaid, Managed Medicaid, and Managed

Passages & reports (14)
  • adjusted EBITDA
  • less
  • NCI was below
  • our internal
  • expectations despite modest sequential improvement.
  • The
  • shortfall primarily reflected a slower than expected ramp up
  • at
  • our de novo hospitals and softer than expected surgical trends. Turning to segment perform…
  • was broad-based geographically and also benefited from capacity additions at three hospita…
  • 2025. Inpatient and outpatient surgical cases declined at similar levels in the quarter. I…
  • and urology similar to recent quarters. By payer class, adjusted admissions growth for Med…
  • above the acute care
  • segment average. Volume growth for Medicaid, Managed Medicaid, and Managed

Speaker 2

Care, excluding exchanges, was positive in the quarter, although below

Passages & reports (1)
  • Care, excluding exchanges, was positive in the quarter, although below

Speaker unclear

?the

Passages & reports (1)
  • the

Speaker 1

segment average. ?On a same facility basis, net revenue in our acute care segment during the third quarter of 2026 increased 4.7%. Excluding the impact of our health plan, same facility acute care net revenue increased 3.1%. Acute care, same facility revenue per adjusted admissions decreased by 1.7% during the third quarter of 2026 on a reported basis and was slightly positive when excluding the net headwind from out-of-period Medicaid supplemental benefits ?and the shift of exchange to uninsured volumes.

We estimate underlying acute care rate growth was approximately 3% and consistent with recent quarters after adjusting for these factors and normalizing for the higher inpatient medical versus surgical mix. Operating expenses continued to be
well managed across labor, supply, and other expense categories. Same facility acute care salaries, wages, and benefits expense per adjusted admission increased 2.1%, and supply expense for adjusted admission decreased

Passages & reports (7)
  • segment average.
  • On
  • a same facility basis, net revenue in our acute care segment during the third quarter of 2…
  • admissions decreased by 1.7% during the third quarter of 2026 on a reported basis and was …
  • and
  • the shift of exchange to uninsured volumes. We estimate underlying acute care rate growth …
  • well managed across labor, supply, and other expense categories. Same facility acute care …

Speaker 2

2.3% over last year's third quarter. Other operating expenses increased primarily due to our health plan, which experienced revenue

Passages & reports (1)
  • 2.3% over last year's third quarter. Other operating expenses increased primarily due to o…

Speaker 1

growth of approximately 25% in the third quarter. Same facility acute Care Segment EBITDA declined 4.5% in the third quarter of 2026, excluding the out-of-period supplemental program benefit from both periods. Third quarter same facility acute care segment EBITDA increased 2.9%. In our ?acute care segment, the net out-of-period headwind related to supplemental payments was $29 million, comprised of $26 million in the third quarter of 2026 from expanded funding under existing programs primarily in Washington, D.C.

and California, compared with $55 million of out-of-period amounts in the third quarter of
2025

Passages & reports (5)
  • growth of approximately 25% in the third quarter. Same facility acute Care Segment EBITDA …
  • 2.9%. In our
  • acute care
  • segment, the net out-of-period headwind related to supplemental payments was $29 million, …
  • 2025

Speaker 3

related to the Washington, D.C. program approved last year. ?For the third quarter of 2026, we estimate that health insurance exchange trends had an impact of slightly less than $25 million, which was consistent with the updated outlook provided in July. Exchange volumes declined 17% from the third quarter of 2025, accompanied by a similar increase in the number of self-pay volumes. ?At Palm Beach Gardens, our acute care de novo hospital remains in the early stages of ramping volumes across multiple service lines.

Startup losses improved each month during the third quarter. While the ramp at this facility remains gradual, the progression supports our expectation for continued improvement as we
enter Florida's seasonally busier winter period. ?In Washington, D.C., Cedar Hill Regional Medical Center operating losses were similar on a sequential basis, excluding supplemental payments. We continue to support the build-out of primary care and specialty physician practices in the community around the hospital and in our MOB.

Because these practices remain at varying
stages of developing their patient bases within the community, we now expect the hospital to reach operational breakeven in the first half of 2027, compared with our prior expectations of the fourth quarter of 2026. Taken together, Palm Beach Gardens and Cedar Hill are progressing, but their pace of maturation remains an important factor in the timing of margin improvement for the acute care segment.

Turning to behavioral health, third quarter same facility net revenue increased 4.0%, supported by a 2.1% increase in same facility revenue per adjusted patient day and a 2.1% increase in same facility adjusted patient
days. Volumes improved modestly compared with recent quarters, reflecting steady demand and greater emphasis on the continuum of outpatient levels of care. Included in our total behavioral health segment results are Talkspace and an acquisition we completed in our UK operations in July, offset by startup losses associated with two de novo projects and ongoing operating losses at Laurel Ridge while we work towards recertification.

Given the mid quarter closing, Talkspace's contribution to third quarter earnings was immaterial.
?In our behavioral health segment, the net out-of-period headwind related to supplemental payments was approximately $8 million in the third quarter of 2026, due primarily to the new Washington, D.C. program benefit in the third quarter of 2025. ?For the third quarter of 2026, behavioral health segments, same facilities' salaries, wages, and benefits per adjusted patient day increased 3.6% over the prior year, improving further on a sequential basis due to continued moderation in headcount growth.

Turning to cash flow and capital allocation,
third quarter cash generated from operating activities was $637 million compared with $381 million during the same period last year. During the third quarter of 2026, we spent $214 million on capital expenditures, and we anticipate capital expenditures to be slightly below $1 billion for the full year of 2026. As several large acute care de novo and expansion projects are now completed, we expect capital expenditures to moderate towards $800 million beyond 2026.

During the third quarter of 2026,
we acquired $1.35 million of our own shares at a total cost of $242 million, bringing year-to-date share repurchases to a total of $690 million. As of September 30, 2026, we had $735 million repurchase authorization available pursuant to our stock buyback program, and we expect to remain active with share repurchase for the foreseeable future. From a balance sheet perspective, we ended the quarter with cash of $169 million, total debt of $5.7 billion, and leverage of $2.17 times.

Total debt reflects the
August refinancing of our September 2026 debt maturity and incremental borrowings associated with the talkspace acquisition. ?As of September 30, 2026, we had approximately $1.2 billion of additional borrowing capacity available pursuant to our revolving credit facility. We remain committed to maintaining leverage within our target range of two to three times. Finally, turning to our 2026 outlook, we are reiterating the financial and operating forecast ranges issued with our second quarter results in July.

Based on year-to-date trends through the third quarter and the ongoing ramp of our acute care hospitals in Washington, D.C. and Palm Beach Gardens, Florida, we currently expect results to be towards the lower end of these ranges.
?The reiterated ranges reflect continued underlying operating improvement, balanced against the pace of de novo facility ramp ups and the other near-term variables discussed today. Operator, that concludes our prepared remarks, and we'd be pleased to answer questions at this time.

Passages & reports (27)
  • related to the Washington, D.C. program approved last year.
  • For
  • the third quarter of 2026, we estimate that health insurance exchange trends had an impact…
  • of self-pay volumes.
  • At
  • Palm Beach Gardens, our acute care de novo hospital remains in the early stages of ramping…
  • enter Florida's seasonally busier winter period.
  • In
  • Washington, D.C., Cedar Hill Regional Medical Center operating losses were similar on a se…
  • stages of developing their patient bases within the community, we now expect the hospital …
  • in the timing of margin improvement for the acute care segment. Turning to behavioral heal…
  • days. Volumes improved modestly compared with recent quarters, reflecting steady demand an…
  • losses associated with two de novo projects and ongoing operating losses at Laurel Ridge w…
  • In
  • our behavioral health segment, the net out-of-period headwind related to supplemental paym…
  • For
  • the third quarter of 2026, behavioral health segments, same facilities' salaries, wages, a…
  • third quarter cash generated from operating activities was $637 million compared with $381…
  • below $1 billion for the full year of 2026. As several large acute care de novo and expans…
  • we acquired $1.35 million of our own shares at a total cost of $242 million, bringing year…
  • buyback program, and we expect to remain active with share repurchase for the foreseeable …
  • August refinancing of our September 2026 debt maturity and incremental borrowings associat…
  • As
  • of September 30, 2026, we had approximately $1.2 billion of additional borrowing capacity …
  • operating forecast ranges issued with our second quarter results in July. Based on year-to…
  • The
  • reiterated ranges reflect continued underlying operating improvement, balanced against the…

Speaker 0

Thank you. We will now open the call to question and answers to allow as many people as possible to submit a question. Please limit yourself to one question and one follow-up. Our first question comes from the line of AJ Rice of UBS. Your line is now open.

Passages & reports (1)
  • Thank you. We will now open the call to question and answers to allow as many people as po…

Questions & answers

Speaker 4

Unverified voice label

Uh thanks. Hi everybody. Um just uh I know it's early and um to be talking about twenty-seven, but uh but some of the companies are, so I'll ask it of you. Uh at least uh how do you think about puts and takes for next year? Uh I guess specifically I can ask you on uh DPP headwinds, supplemental payment headwinds next year, uh given some out of period recognition this year, and uh early thoughts on incremental uh public exchange uh headwind, if

Passages & reports (2)
  • Uh thanks. Hi everybody. Um just uh I know it's early and um to be talking about twenty-se…
  • ask you on uh DPP headwinds, supplemental payment headwinds next year, uh given some out o…

Speaker unclear

?any.

Passages & reports (1)
  • any.

Speaker 3

Yeah, so I I would just remind everybody, AJ, that consistent with prior years, we plan to issue our full comprehensive 2027 guidance in February when we report our fourth quarter results. We feel good about the core elements of our 2026 growth algorithm guidance in both segments, which we went through last quarter. Outside of that, we can point to a few items, a couple of which you mentioned, uh in terms of you know material headwinds and tailwinds as we know begin to think about 2027. ?

The
biggest swing factors, I think, in 2027 relate to improvements at facilities that are incurring operating losses during 2026, particularly the Laurel Ridge San Antonio facility that we talked about and the two acute care de novos that we mentioned in our prepared remarks. Cumulatively, these facilities are expected to contribute operating losses of $80 to $100 million in 2026. And we believe there is potential to recover at least a meaningful portion of those losses in 2027 as we anticipate making further operational progress at the de novo facilities over the next several quarters and regaining certification at the San Antonio facility. ?

As
it relates to San Antonio, I I would just note we're making progress towards recertification and remain confident that we'll we'll achieve that in 2027, giving us a path to rebuild census in a deliberate manner. ?On the headwind side, and I think you mentioned a couple of these things, the biggest swing factors relate to regulatory changes that continue to play out in the operating environment, particularly the impact from the exchanges, the potential impact of Medicaid work requirements, and the initial impact of reductions to Medicaid supplemental funding. ?

We
also had a material amount of prior year DPP benefit in calendar year 26 that will not repeat in 2027. As it relates to Medicaid supplemental payments, we estimate the 2027 headwind will be approximately 175 to 200 million dollars. This primarily includes prior year amounts that we recorded in 2026 for DPP programs in Florida, Nevada, Ohio, California, and Washington, D.C., as well as approximately $10 million of impact during the fourth quarter of 2027 from the initial provider tax portion of the OB3 funding cuts.

As it relates to the exchanges, annualizing the second half 2026 run
rate would create a $15 million headwind in 2027. Further changes in exchange enrollment could increase that number, and we'll have greater insight into that following the open enrollment period. ?As it relates to Medicaid work requirements, it's difficult to provide an estimate on the potential impact because the implementation timing may lag up to six months in certain states.

More importantly, the state-specific regulatory guidance related to the medical frailty exceptions remains a key open item. Our baseline assumption is
that the impact of Medicaid work requirements with the will be primarily concentrated in Medicaid expansion states, and that a vast majority of behavioral health patients and a meaningful portion of our acute care patients could be exempt from work requirements because their diagnoses meet the medical frailty exemption.

As investors develop estimates
on work requirements, it's worth noting from a volume perspective, Medicaid volumes and expansion states represented approximately 15% of our total acute care segment adjusted admissions and 30% of total behavioral health segment patient days. Broadly, I think, as most investors know, Medicaid revenue per unit of volume is lower than other payers. So as you do those calculations, you should keep those in mind.

Passages & reports (18)
  • Yeah, so I I would just remind everybody, AJ, that consistent with prior years, we plan to…
  • of that, we can point to a few items, a couple of which you mentioned, uh in terms of you …
  • The
  • biggest swing factors, I think, in 2027 relate to improvements at facilities that are incu…
  • to $100 million in 2026. And we believe there is potential to recover at least a meaningfu…
  • As
  • it relates to San Antonio, I I would just note we're making progress towards recertificati…
  • On
  • the headwind side, and I think you mentioned a couple of these things, the biggest swing f…
  • We
  • also had a material amount of prior year DPP benefit in calendar year 26 that will not rep…
  • for DPP programs in Florida, Nevada, Ohio, California, and Washington, D.C., as well as ap…
  • rate would create a $15 million headwind in 2027. Further changes in exchange enrollment c…
  • As
  • it relates to Medicaid work requirements, it's difficult to provide an estimate on the pot…
  • that the impact of Medicaid work requirements with the will be primarily concentrated in M…
  • on work requirements, it's worth noting from a volume perspective, Medicaid volumes and ex…
  • unit of volume is lower than other payers. So as you do those calculations, you should kee…

Speaker 4

Oh, that's uh very helpful. Thanks for that. Um you've you've had very strong volumes. Obviously, it's been a shift, it looks like, to medical from uh surgical. I wondered if you could uh drill down just and talk a little bit about service lines. What's been strong on the medical side and are you attributing the softness in surgery mainly to public exchange disenrollment or s uh economy or something else?

Passages & reports (3)
  • Oh, that's uh very helpful. Thanks for that. Um
  • you've you've had very strong volumes. Obviously, it's been a shift, it looks like, to med…
  • public exchange disenrollment or s uh economy or something else?

Speaker 3

Yeah, I I think from our perspective, AJ, um the trend um towards uh a slightly weaker surgical mix is ?uh an acceleration of an of existing trends that we've seen for some time and that is the continued shift of procedures, both in and outpatient procedures, out of the hospital, in and outpatient services, and into alternative settings, whether they are ASCs or physician offices.

And we really see this in
particular in certain service lines. So GI as an example, we've seen just an accelerated shift of procedures both in and outpatient into alternative settings and out of the hospital. A number of orthopedic procedures as well. You know, we mentioned in our prepared remarks some of the service lines that have been performing fairly robustly. That those included cardiology, neurology, ?uh, and urology.

Um, but yeah, I I I think again, in our minds, uh what what we're just seeing is this accelerated shift of procedures into these alternative settings.

Passages & reports (7)
  • Yeah, I I think from our perspective, AJ, um the trend um towards uh a slightly weaker sur…
  • uh
  • an acceleration of an of existing trends that we've seen for some time and that is the con…
  • particular in certain service lines. So GI as an example, we've seen just an accelerated s…
  • lines that have been performing fairly robustly. That those included cardiology, neurology…
  • uh,
  • and urology. Um, but yeah, I I I think again, in our minds, uh what what we're just seeing…

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Ann Hines of Mizuho. Your line is now

Passages & reports (1)
  • Our next question comes from the line of Ann Hines of Mizuho. Your line is now

Speaker unclear

?open.

Passages & reports (1)
  • open.

Speaker 5

Unverified voice label

Great, thank you. Just the two acute facilities that are um not ramping as you thought. What's driving that slower ramp? Is there anything structural or challenges that you face? ?Um I mean I've been covering the company for a long time, and I don't remember a time where like the new acute care hospitals are ramping below expectations. So if you can just go into each market and what's driving um the loss versus your expectations, that would be great.

Thank

Passages & reports (3)
  • Great, thank you. Just the two acute facilities that are um not ramping as you thought. Wh…
  • Um
  • I mean I've been covering the company for a long time, and I don't remember a time where l…

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 3

Yeah, so um I'll address Cedar Hill first. Cedar Hill in Washington, DC opened in April of 2025. And I think as we've been commenting um consistently since that opening, uh it opened with a busy emergency room uh activity, and emergency room activity has remained busy since its opening. Um, but what has lagged uh has been um a you know busier surgical and procedural schedule.

And I think the reason for that primarily is a lack of physician infrastructure in that part of the Washington, D.C. market. For years, and this is
for those of you familiar with Washington, D.C., in Ward 7 and 8, there was really a lack of quality health care, and patients were leaving Ward 7 and 8 to get their health care elsewhere in the city.

And as a consequence, you know, doctors really were not locating in Ward 7 and 8,
doctor offices were not. And as we indicated in our prepared remarks, we've addressed that by working with a number of different physicians and physician groups to establish practices in Ward 7 and 8, within Ward 7 and 8, in the MOB adjacent to our hospital, et cetera.

Passages & reports (4)
  • Yeah, so um I'll address Cedar Hill first. Cedar Hill in Washington, DC opened in April of…
  • its opening. Um, but what has lagged uh has been um a you know busier surgical and procedu…
  • for those of you familiar with Washington, D.C., in Ward 7 and 8, there was really a lack …
  • doctor offices were not. And as we indicated in our prepared remarks, we've addressed that…

But those practices are relocating and they're developing, but they're in different stages of development. And that takes some time. And I think that's been the major issue in terms of the timing of the development of Cedar Hill. Structurally, I think we believe that all the things that we thought about what would make this hospital successful are still there and will do so, just taking somewhat longer.

The other nuanced comment that I'll make, and I I think I made it last quarter as well, as it relates to Cedar Hill, is that the arrangement we had with the district in entering uh
the Cedar Hill uh partnership with the district was that they would build and essentially finance the construction of Cedar Hill. So the absolute amounts of earnings, the absolute margins that we're going to have to achieve at Cedar Hill to get to our sort of target rates of return will be less than in those hospitals where we've built and invested the hundreds of millions of dollars to build the hospitals.

As far as the facility in Palm Beach Gardens goes, I think that honestly, one of the biggest challenges we had at at its opening was that we opened in the beginning of the summer, um, which is
a difficult time to open as you might imagine in South Florida. It was not our original intent. We had originally uh planned to open earlier and take advantage of the uh the busy season in Florida, but you know, construction delays sort of um you know made that impossible.

So I think by opening
in the summertime we got off to a bit of a slower start, but expect the facility, and I think again in our prepared comments, we indicated the facility is you know getting better, volumes are increasing every month, uh, and we expect that to accelerate as the busy season sort of ramps up in Florida over the next several months. ?

Uh
I'll reiterate the same comment. No, structurally, I think everything we believed about the potential success of that hospital is still uh can you know consistent with our original views, uh just taking a little bit longer to ramp up than we originally anticipated.

Passages & reports (9)
  • But those practices are relocating and they're developing, but they're in different stages…
  • thought about what would make this hospital successful are still there and will do so, jus…
  • the Cedar Hill uh partnership with the district was that they would build and essentially …
  • those hospitals where we've built and invested the hundreds of millions of dollars to buil…
  • a difficult time to open as you might imagine in South Florida. It was not our original in…
  • in the summertime we got off to a bit of a slower start, but expect the facility, and I th…
  • Florida over the next several months.
  • Uh
  • I'll reiterate the same comment. No, structurally, I think everything we believed about th…

Speaker 5

Thanks

Passages & reports (1)
  • Thanks

Speaker unclear

?for the

Passages & reports (1)
  • for the

Speaker 0

Our next question comes from the line of Justin Lake of Wolf Research. Your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Justin Lake of Wolf Research. Your line is now op…

Speaker 4

Thanks. Good morning. Just a couple of numbers questions here. Steve, maybe you can break down the eighty

Passages & reports (1)
  • Thanks. Good morning. Just a couple of numbers questions here. Steve, maybe you can break …

Speaker 6

Unverified voice label

to a hundred million of uh losses

Passages & reports (1)
  • to a hundred million of uh losses

Speaker 4

between those uh those three facilities and uh Laurel Ridge in particular. What were the uh what were the operating profits there when it was open? ?So we can get an idea

Passages & reports (3)
  • between those uh those three facilities and uh Laurel Ridge in particular. What were the u…
  • So
  • we can get an idea

Speaker 6

of what it could recover to, and maybe uh Mark can give us any timeline he thinks you know within 2027 when you're thinking that might that might come uh back online. Thanks.

Passages & reports (1)
  • of what it could recover to, and maybe uh Mark can give us any timeline he thinks you know…

Speaker 2

Yeah, I mean we're we're confident that we're gonna be back online sooner than later, but we don't have an exact date in 2027. We're still working with all the regulatory agencies, things are going well. Um that will uh ?you know be back to where we were we we expect in 2027, but I can't give you an exact date.

Passages & reports (3)
  • Yeah, I mean we're we're confident that we're gonna be back online sooner than later, but …
  • you
  • know be back to where we were we we expect in 2027, but I can't give you an exact date.

Speaker unclear

?And

Passages & reports (1)
  • And

Speaker 3

as far as the numbers go, Justin, you know, when we first announced the loss of certification at Laurel Ridge, we

Passages & reports (1)
  • as far as the numbers go, Justin, you know, when we first announced the loss of certificat…

Speaker unclear

?disclosed

Passages & reports (1)
  • disclosed

Speaker 1

that last year the pre-tax income at that facility was in the 2025 million dollar range. We've talked about incurring since it has lost its certification, but has continued

Passages & reports (1)
  • that last year the pre-tax income at that facility was in the 2025 million dollar range. W…

Speaker unclear

?to treat a small number of

Passages & reports (1)
  • to treat a small number of

Speaker 3

patients, that we expect it will lose five or ten million dollars a quarter each quarter that we remain open without without certification. We've talked about Cedar Hill over the last several quarters ?losing roughly $10 ?million a month. ?And as far as the Palm Beach Gardens Hospital, you can pretty much get that from looking at the difference between our

Passages & reports (7)
  • patients, that we expect it will lose five or ten million dollars a quarter each quarter t…
  • losing
  • roughly $10
  • million
  • a month.
  • And
  • as far as the Palm Beach Gardens Hospital, you can pretty much get that from looking at th…

Speaker 1

same-store acute results and our full acute care results, but you know

Passages & reports (1)
  • same-store acute results and our full acute care results, but you know

Speaker 3

lost

Passages & reports (1)
  • lost

Speaker 1

about $15 million in this quarter, expected to improve a little bit in Q4, and then continue to improve gradually from

Passages & reports (1)
  • about $15 million in this quarter, expected to improve a little bit in Q4, and then contin…

Speaker unclear

?there.

Passages & reports (1)
  • there.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Matthew Gilmore of Key Bank. Your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Matthew Gilmore of Key Bank. Your line is now ope…

Speaker 4

Hey, thanks for the question. You call that labor as a positive factor in the quarter. I was hoping you can elaborate what you're seeing in terms of wage growth or turnover or use of contract labor.

Passages & reports (1)
  • Hey, thanks for the question. You call that labor as a positive factor in the quarter. I w…

Speaker 3

Yeah, so I think a little bit different story in the in the two segments. You know, I think in the behavioral segment, we talked uh over the course of several quarters that we had sort of invested in, I'm gonna describe it as outsized headcount growth. Uh because we've we've discussed, I think, for for quite some time, that in some of our behavioral facilities and markets uh we were our volume growth was muted because of a constraint in staffing, not enough nurses or therapists or um the non professional techs that are that are important to care in the in the behavioral segment.

Um
but as you know we we've accomplished that I think headcount growth has continued to decelerate. It decelerated in the um in the third quarter, I think it rose by about one and a half percent. And I think going forward uh headcount growth in the behavioral segment will largely be aligned with volume growth.

Passages & reports (3)
  • Yeah, so I think a little bit different story in the in the two segments. You know, I thin…
  • for quite some time, that in some of our behavioral facilities and markets uh we were our …
  • but as you know we we've accomplished that I think headcount growth has continued to decel…

So you know that's a been a benefit uh and an improvement in the behavioral health segment. ?I think in the acute segment, you know, as your question sort of alluded to to, um, you know, our uh we've seen a fairly significant reduction in uh temporary and traveling labor. Um I think that has risen you know in the most recent quarter by like three percent so it is well controlled.

And
I think wage inflation um you know has certainly come down from its heights during the pandemic to ?uh you know something in the three, three and a half percent range in both segments.

Passages & reports (6)
  • So you know that's a been a benefit uh and an improvement in the behavioral health segment…
  • I
  • think in the acute segment, you know, as your question sort of alluded to to, um, you know…
  • I think wage inflation um you know has certainly come down from its heights during the pan…
  • uh
  • you know something in the three, three and a half percent range in both segments.

Speaker unclear

?Got it. And then if I

Passages & reports (1)
  • Got it. And then if I

Speaker 4

could follow up on

Passages & reports (1)
  • could follow up on

Speaker unclear

?the Talkspace

Passages & reports (1)
  • the Talkspace

Speaker 7

Unverified voice label

acquisition, it sounds like you'll you'll share more on the fourth quarter call about the integration and synergy opportunity. I wanted to see if you'd be willing to discuss, you know, will there be synergies that you think you'll be able to pull through during the 2027 period, or is that a longer term priority?

Passages & reports (1)
  • acquisition, it sounds like you'll you'll share more on the fourth quarter call about the …

Speaker 3

So, you know, what we said originally, uh, Matt, um, when we disclosed the talkspace

Passages & reports (1)
  • So, you know, what we said originally, uh, Matt, um, when we disclosed the talkspace

Speaker 1

acquisition is that

Passages & reports (1)
  • acquisition is that

Speaker unclear

?our

Passages & reports (1)
  • our

Speaker 3

expectation in the

Passages & reports (1)
  • expectation in the

Speaker unclear

?first

Passages & reports (1)
  • first

Speaker 1

12 months of ownership, which would be into the third quarter of next year,

Passages & reports (1)
  • 12 months of ownership, which would be into the third quarter of next year,

Speaker unclear

?was that the transaction would be slightly accretive.

Passages & reports (1)
  • was that the transaction would be slightly accretive.

Speaker 3

There's a very small amount of overhead and cost savings, sort of duplicative

Passages & reports (1)
  • There's a very small amount of overhead and cost savings, sort of duplicative

Speaker unclear

?cost savings, as we combine two public companies. But the vast

Passages & reports (1)
  • cost savings, as we combine two public companies. But the vast

Speaker 1

majority of synergies are revenue synergies.

Passages & reports (1)
  • majority of synergies are revenue synergies.

Speaker unclear

?And the opportunity that combining

Passages & reports (1)
  • And the opportunity that combining

Speaker 3

the lower acuity population, patient population that TalkSpace has, and the higher acuity patient population that UHS has really creates this robust continuum of care that really doesn't exist anywhere else in the behavioral space. And that's the opportunity. As far as the timing of it, you know, I think we'll begin to realize that. And we said this in ?our prepared remarks in the first 12

Passages & reports (4)
  • the lower acuity population, patient population that TalkSpace has, and the higher acuity …
  • you know, I think we'll begin to realize that. And we said this in
  • our prepared
  • remarks in the first 12

Speaker unclear

?to 24 months of ownership.

Passages & reports (1)
  • to 24 months of ownership.

Speaker 1

So beginning in the back half of next year, and as we I think noted in our remarks, ?I think we'll be more specific about that and how much of that we've included in our guidance when we uh when

Passages & reports (3)
  • So beginning in the back half of next year, and as we I think noted in our remarks,
  • I
  • think we'll be more specific about that and how much of that we've included in our guidanc…

Speaker unclear

?we present guidance in

Passages & reports (1)
  • we present guidance in

Speaker 2

February. But um, ?you know, as Mark indicated in his remarks, we're certainly beginning to focus on those revenue synergies and create all the changes in policies and procedures and infrastructure and technology that we'll need

Passages & reports (3)
  • February. But um,
  • you know,
  • as Mark indicated in his remarks, we're certainly beginning to focus on those revenue syne…

Speaker 1

to execute on those synergies next

Passages & reports (1)
  • to execute on those synergies next

Speaker unclear

?year.

Passages & reports (1)
  • year.

Speaker 7

Great. Thank

Passages & reports (1)
  • Great. Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Steven Baxter. Wells Fargo, your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Steven Baxter. Wells Fargo, your line is now open…

Speaker unclear

?Hi, thanks. Uh I

Passages & reports (1)
  • Hi, thanks. Uh I

Speaker 4

wanted to ask

Passages & reports (1)
  • wanted to ask

Speaker 7

about ?the uh the same store acute revenue per adjusted emission in the quarter. ?I guess how should we think about what that figure would be if we were to exclude uh all change in year over year Medicaid supplemental? I guess just not just the at a period components. ?I guess how did that compare to your expectations and how much of a pressure is the surgical decline putting on those metrics?

Thanks.

Passages & reports (7)
  • about
  • the
  • uh the same store acute revenue per adjusted emission in the quarter.
  • I
  • guess how should we think about what that figure would be if we were to exclude uh all cha…
  • I
  • guess how did that compare to your expectations and how much of a pressure is the surgical…

Speaker 3

Yeah,

Passages & reports (1)
  • Yeah,

Speaker 1

so again, in in the

Passages & reports (1)
  • so again, in in the

Speaker 3

remarks, I think we called out three items that I think are um putting pressure on that, you know, revenue per adjusted admission metric in the quarter. Uh, and I think you tick through them. You know, one is the impact of

Passages & reports (1)
  • remarks, I think we called out three items that I think are um putting pressure on that, y…

Speaker unclear

?the

Passages & reports (1)
  • the

Speaker 2

exchanges. Um,

Passages & reports (1)
  • exchanges. Um,

Speaker unclear

?while that's you know playing out, I

Passages & reports (1)
  • while that's you know playing out, I

Speaker 3

think, consistent with our expectations, it's certainly a drag compared ?to last year. Then there's the out-of-period DPP, which we talked about, and then the

Passages & reports (3)
  • think, consistent with our expectations, it's certainly a drag compared
  • to last year. Then
  • there's the out-of-period DPP, which we talked about, and then the

Speaker unclear

?med surge mix pressure, which we talked about.

Passages & reports (1)
  • med surge mix pressure, which we talked about.

Speaker 3

We think the med

Passages & reports (1)
  • We think the med

Speaker 1

surge mix pressure probably reduces the growth in revenue per adjusted emission by about 100 basis points. We think if you we adjust for all three of those items, uh revenue per admission would have been up in the in the 3% range, which is you know in

Passages & reports (1)
  • surge mix pressure probably reduces the growth in revenue per adjusted emission by about 1…

Speaker unclear

?in you know

Passages & reports (1)
  • in you know

Speaker 2

within the range that we've talked ?about as the sustainable going forward range for pricing.

Passages & reports (3)
  • within the range that we've talked
  • about as
  • the sustainable going forward range for pricing.

Speaker 7

Okay. When you look at the improvement in acute volumes that you saw in the quarter, is there any meaningful difference in either like geographic strength or different payer strengths you want to call

Passages & reports (1)
  • Okay. When you look at the improvement in acute volumes that you saw in the quarter, is th…

Speaker unclear

?out? I

Passages & reports (1)
  • out? I

Speaker 3

think it's pretty broad-based geographically. We talked a little bit about payer

Passages & reports (1)
  • think it's pretty broad-based geographically. We talked a little bit about payer

Speaker unclear

?mix

Passages & reports (1)
  • mix

Speaker 1

in ?our remarks. I think you know Medicare is growing faster than the divisional average. Medicaid and commercial are growing a little bit, are both positive but growing a little bit slower than the divisional average. And

Passages & reports (3)
  • in
  • our
  • remarks. I think you know Medicare is growing faster than the divisional average. Medicaid…

Speaker unclear

?we've seen

Passages & reports (1)
  • we've seen

Speaker 2

an increase in self-pay or uncompensated care, largely sort of a one-for-one swap in the decline for exchanges. I think the only other the only other geographic

Passages & reports (1)
  • an increase in self-pay or uncompensated care, largely sort of a one-for-one swap in the d…

Speaker unclear

?note

Passages & reports (1)
  • note

Speaker 1

I would make, and it's probably more a fourth ?quarter note, is that ?last year we had ?a pretty soft fourth quarter in the Vegas market. They had

Passages & reports (7)
  • I would make, and it's probably more a fourth
  • quarter
  • note, is that
  • last
  • year we had
  • a pretty
  • soft fourth quarter in the Vegas market. They had

Speaker 2

a very light flu

Passages & reports (1)
  • a very light flu

Speaker unclear

?season in a in a year in which almost everybody else had a pretty um acute flu season. So I think

Passages & reports (1)
  • season in a in a year in which almost everybody else had a pretty um acute flu season. So …

Speaker 1

you know we're we're thinking about that as a bit of a tailwind for us in the fourth quarter. But otherwise, you know, the the

Passages & reports (1)
  • you know we're we're thinking about that as a bit of a tailwind for us in the fourth quart…

Speaker unclear

?strength in in cube

Passages & reports (1)
  • strength in in cube

Speaker 2

volumes has been pretty broad geographically.

Passages & reports (1)
  • volumes has been pretty broad geographically.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Kevin Fishbeck of B of A. Your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Kevin Fishbeck of B of A. Your line is now open.

Speaker unclear

?Great, thanks. I

Passages & reports (1)
  • Great, thanks. I

Speaker 7

wanna go back to your answer ?about the the surgical volume um

Passages & reports (3)
  • wanna go back to your answer
  • about the the surgical
  • volume um

Speaker unclear

?coming in a little bit lower

Passages & reports (1)
  • coming in a little bit lower

Speaker 3

than what you guys were thinking about and and kind of attributing that to the acceleration of recent uh trends. You know, what would you attribute that acceleration to though? Is it is there something specific? Is it the IPO or is it um you know something else? I just try to figure out how long this acceleration might last um and and be better to understand uh you know what's causing

Passages & reports (2)
  • than what you guys were thinking about and and kind of attributing that to the acceleratio…
  • long this acceleration might last um and and be better to understand uh you know what's ca…

Speaker unclear

?it. Uh so so first Kevin I would say I don't think it's the

Passages & reports (1)
  • it. Uh so so first Kevin I would say I don't think it's the

Speaker 2

inpatient only dynamic. When we

Passages & reports (1)
  • inpatient only dynamic. When we

Speaker 1

looked at the procedures covered by the inpatient-only regs, I think we concluded that most of our procedures that fall into that those categories were procedures that had more than a two-midnight stay ?and appeared to ?us to be

Passages & reports (5)
  • looked at the procedures covered by the inpatient-only regs, I think we concluded that mos…
  • and
  • appeared to
  • us to
  • be

Speaker unclear

?more

Passages & reports (1)
  • more

Speaker 3

acute than would allow them to really be transfor tr transferred or evolved into

Passages & reports (1)
  • acute than would allow them to really be transfor tr transferred or evolved into

Speaker unclear

?outpatient procedures. Yeah you know I I I don't know that I have a great

Passages & reports (1)
  • outpatient procedures. Yeah you know I I I don't know that I have a great

Speaker 3

explanation for exactly why we

Passages & reports (1)
  • explanation for exactly why we

Speaker unclear

?and I think the industry in general has seen this acceleration

Passages & reports (1)
  • and I think the industry in general has seen this acceleration

Speaker 3

in certain procedures to outpatient.

Passages & reports (1)
  • in certain procedures to outpatient.

Speaker unclear

?But you

Passages & reports (1)
  • But you

Speaker 1

know,

Passages & reports (1)
  • know,

Speaker unclear

?I'll describe one of the challenges

Passages & reports (1)
  • I'll describe one of the challenges

Speaker 2

we see, and I'll use GI as ?an example, is that as more and more GI procedures are being done outside of the hospital and largely in physician offices and in ASCs, we have found it difficult even to get GIs ?to cover our emergency rooms. We either can't get them to do it at all, or the expense of doing it and the cost of doing it is uh is really sort of outsized.

And so as a consequence, in some of our facilities, even our emergency room visits that are GI related are being diverted to
someplace else because we just don't have the coverage. So I think there's a bit of a ?sort of

Passages & reports (8)
  • we see, and I'll use GI as
  • an
  • example, is that as more and more GI procedures are being done outside of the hospital and…
  • to cover
  • our emergency rooms. We either can't get them to do it at all, or the expense of doing it …
  • someplace else because we just don't have the coverage. So I think there's a bit of a
  • sort
  • of

Speaker unclear

?compounding effect that as more and more of these procedures, elective procedures move into outpatient settings in some of these areas. And again, I think GI sort of stands out for us. Even the emergency procedures that that would have traditionally come through

Passages & reports (1)
  • compounding effect that as more and more of these procedures, elective procedures move int…

Speaker 1

our emergency rooms are being diverted

Passages & reports (1)
  • our emergency rooms are being diverted

Speaker unclear

?elsewhere.

Passages & reports (1)
  • elsewhere.

Speaker 4

Okay,

Passages & reports (1)
  • Okay,

Speaker unclear

?great. And

Passages & reports (1)
  • great. And

Speaker 3

then I guess ?as one of the, you ?know, I guess the tailwinds that you mentioned in 2027, you just ?said the long-term growth algorithm. If you just remind us of that, I know that like this year you're looking for four and a half to seven, six and a half on acute and three to five on behavioral. Is that what you're talking about?

Passages & reports (7)
  • then I guess
  • as one of
  • the, you
  • know,
  • I guess the tailwinds that you mentioned in 2027, you just
  • said
  • the long-term growth algorithm. If you just remind us of that, I know that like this year …

Speaker unclear

?Or are we talking about something a

Passages & reports (1)
  • Or are we talking about something a

Speaker 3

little bit different? ?No, I think in in

Passages & reports (3)
  • little bit different?
  • No,
  • I think in in

Speaker 2

uh last quarter

Passages & reports (1)
  • uh last quarter

Speaker unclear

?we sort of laid out our our

Passages & reports (1)
  • we sort of laid out our our

Speaker 1

growth algorithms

Passages & reports (1)
  • growth algorithms

Speaker unclear

?for the two segments in acute care. Uh we're talking

Passages & reports (1)
  • for the two segments in acute care. Uh we're talking

Speaker 2

about one and a half to two and a half percent adjusted admission growth. Um For the year, I think we're

Passages & reports (1)
  • about one and a half to two and a half percent adjusted admission growth. Um For the year,…

Speaker 1

averaging slightly above that, I think 2.6% for the year, and then 2-3% pricing growth. As I mentioned in my previous response, we believe you sort of adjust for all these exogenous factors. We're running, you know, at around that 3% in the quarter, so at the low end

Passages & reports (1)
  • averaging slightly above that, I think 2.6% for the year, and then 2-3% pricing growth. As…

Speaker unclear

?of that range. On the behavioral side, we we we you know modified

Passages & reports (1)
  • of that range. On the behavioral side, we we we you know modified

Speaker 2

our ?growth algorithm, our adjusted patient day growth algorithm to 1% to 2% last quarter. Uh and I think we're running for the year in the 1.7% range, so kind of towards the higher end of that range. And then 2-3% pricing in behavioral. And ?I think we are running, running within that range in behavioral as

Passages & reports (5)
  • our
  • growth algorithm, our
  • adjusted patient day growth algorithm to 1% to 2% last quarter. Uh and I think we're runni…
  • I
  • think we are running, running within that range in behavioral as

Speaker unclear

?well.

Passages & reports (1)
  • well.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Craig Hattenbach of Morgan Stanley. Your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Craig Hattenbach of Morgan Stanley. Your line is …

Speaker 3

Yes, thank you. Just following up on Talkspace and understanding it's recently closed, but if you can just give some context of how that business is performing, kind of growth rates you expect. And then as a follow-up on that, you you mentioned kind of the unique offering across mental health. How are you thinking about that in terms of implications of payer relationships on a longer term basis as the strategy unfolds?

Passages & reports (2)
  • Yes, thank you. Just following up on Talkspace and understanding it's recently closed, but…
  • about that in terms of implications of payer relationships on a longer term basis as the s…

Speaker 2

So this is Mark. As we're integrating Talkspace, I mean one of the big things when we talk about the continuum, talkspace was acquiring patients in a distinct way, having nothing to do with patients coming from other behavioral health settings primarily. That opportunity now exists for us to send patients, refer patients over to Talkspace who are already in our ecosystem, whether in our outpatient settings or in our inpatient settings.

Passages & reports (2)
  • So this is Mark. As we're integrating Talkspace, I mean one of the big things when we talk…
  • settings primarily. That opportunity now exists for us to send patients, refer patients ov…

Conversely, we have an opportunity now, and we're just starting to see this where there are patients that are in that talkspace ecosystem that if they need further care, higher level of care, they're getting directly referred now to us within our own our own system here. So those opportunities didn't exist on either end previously, they exist now, and we're just starting to see some of that come to fruition.

I can't give you exact numbers yet, but we feel like we're off to a good start. The Talkspace folks have been very
encouraged by the way that this has been set up thus far. Again, we're only into this for a few months, but the teams are working very well together. So we're very optimistic going forward that this is going to make a real difference for us and for their business.

Passages & reports (3)
  • Conversely, we have an opportunity now, and we're just starting to see this where there ar…
  • own our own system here. So those opportunities didn't exist on either end previously, the…
  • encouraged by the way that this has been set up thus far. Again, we're only into this for …

Speaker unclear

?Helpful. Thank you. And then

Passages & reports (1)
  • Helpful. Thank you. And then

Speaker 3

just maybe just following on to that as you think about what ?you have today. How are you thinking about just organic in terms of the outpatient push and then maybe even other tuck-ins around kind of virtual more broadly?

Passages & reports (3)
  • just maybe just following on to that as you think about what
  • you have
  • today. How are you thinking about just organic in terms of the outpatient push and then ma…

Speaker unclear

?You're

Passages & reports (1)
  • You're

Speaker 2

talking about non-talk space?

Passages & reports (1)
  • talking about non-talk space?

Speaker 3

Yeah.

Passages & reports (1)
  • Yeah.

Speaker 2

Yeah. I mean, we continue. Look, we we um we've always had a robust uh outpatient business, especially with our intensive outpatients, some of our pet partial uh hospitalization programs, but we're trying to expand even those in some of our locations where we didn't have it uh at all or we didn't have it uh as much. So um, you know, we're certainly focused on that.

We also have what we've talked about in previous quarters, uh Thousand Branches, which has been a newer effort in the last couple of years to expand into different areas in outpatient. That's been going well, um,
and we see further opportunities on the horizon uh to continue that expansion. As far as other tuck-ins, other acquisitions, we're constantly looking, we're um contacted uh often about that.

And if something makes sense uh price-wise, we'll certainly pursue it. But uh right now I think that we're
um moving in the right direction in the areas that I just mentioned.

Passages & reports (4)
  • Yeah. I mean, we continue. Look, we we um we've always had a robust uh outpatient business…
  • or we didn't have it uh as much. So um, you know, we're certainly focused on that. We also…
  • and we see further opportunities on the horizon uh to continue that expansion. As far as o…
  • um moving in the right direction in the areas that I just mentioned.

Speaker 4

Helpful. Thank

Passages & reports (1)
  • Helpful. Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our next question comes from the line of Jason Casurla of Guggenheim Securities. Your line is now open.

Passages & reports (1)
  • Our next question comes from the line of Jason Casurla of Guggenheim Securities. Your line…

Speaker 4

Great,

Passages & reports (1)
  • Great,

Speaker 3

thanks. Good morning. Um wanted to ask about behavioral. Uh obviously strong volume up two point one, same facility up four or revenue up four, excluding out of period uh supplemental same facility EBITDA was only effectively flat. ?I guess can you help in terms of the disconnect

Passages & reports (3)
  • thanks. Good morning. Um wanted to ask about behavioral. Uh obviously strong volume up two…
  • I
  • guess can you help in terms of the disconnect

Speaker unclear

?on the EBITDA growth side? Um

Passages & reports (1)
  • on the EBITDA growth side? Um

Speaker 6

is that ?almost entirely explained ?by Laurel Ridge? Um and same facility EBITDA growth or behavioral would have otherwise been in line with revenue growth, or ?are there puts and takes there?

Passages & reports (7)
  • is that
  • almost entirely
  • explained
  • by
  • Laurel Ridge? Um and same facility EBITDA growth or behavioral would have otherwise been i…
  • are
  • there puts and takes there?

Speaker 4

Thanks.

Passages & reports (1)
  • Thanks.

Speaker unclear

?No,

Passages & reports (1)
  • No,

Speaker 1

I I think, Jason, you know, in some to a large degree, you've answered your own question. Yeah. So I think that lower range is probably the single biggest drag on the behavioral earnings improvement. Beyond that, as I said earlier, as we think about revenue growth from

Passages & reports (1)
  • I I think, Jason, you know, in some to a large degree, you've answered your own question. …

Speaker unclear

?a volume pricing perspective, I think we're running towards the

Passages & reports (1)
  • a volume pricing perspective, I think we're running towards the

Speaker 1

high end of our range for volumes, expected volumes, towards the lower end of our range in pricing. I think some of that is a reflection of the fact that over the last several years pricing has been very robust. Some of that has

Passages & reports (1)
  • high end of our range for volumes, expected volumes, towards the lower end of our range in…

Speaker 2

been the benefit of DPP, but even when you exclude that, our pricing ?and our contractual

Passages & reports (3)
  • been the benefit of DPP, but even when you exclude that, our pricing
  • and
  • our contractual

Speaker unclear

?pricing has been very robust as

Passages & reports (1)
  • pricing has been very robust as

Speaker 1

we've been getting contractual price increases from payers, particularly managed Medicaid payers, who have not given us increases for several years. Unfortunately, obviously, after several years of that, we've started to anniversary

Passages & reports (1)
  • we've been getting contractual price increases from payers, particularly managed Medicaid …

Speaker 2

some of that benefit,

Passages & reports (1)
  • some of that benefit,

Speaker unclear

?and the

Passages & reports (1)
  • and the

Speaker 1

pricing I

Passages & reports (1)
  • pricing I

Speaker unclear

?think has been moved into that two to three percent

Passages & reports (1)
  • think has been moved into that two to three percent

Speaker 1

range. But I think we're fairly confident that we'll

Passages & reports (1)
  • range. But I think we're fairly confident that we'll

Speaker unclear

?be able to sustain that.

Passages & reports (1)
  • be able to sustain that.

Speaker 2

And as we go into

Passages & reports (1)
  • And as we go into

Speaker unclear

?you know next year, et cetera,

Passages & reports (1)
  • you know next year, et cetera,

Speaker 1

those comparisons will

Passages & reports (1)
  • those comparisons will

Speaker unclear

?become easier. Got it. Thanks. Uh very helpful.

Passages & reports (1)
  • become easier. Got it. Thanks. Uh very helpful.

Speaker 3

And maybe just as a follow-up, um

Passages & reports (1)
  • And maybe just as a follow-up, um

Speaker unclear

?I wanted to

Passages & reports (1)
  • I wanted to

Speaker 4

ask about the $10

Passages & reports (1)
  • ask about the $10

Speaker unclear

?million Medicaid

Passages & reports (1)
  • million Medicaid

Speaker 3

supplemental headwind that you flagged for the fourth quarter of 27. Maybe could you just expand on how you're thinking about that estimate or you know um which state programs are impacted in that quarter? Um I know that the uh rules out there are still proposed, but just any other color related to that fourth quarter 27 headwind and then any updates you may have around um the potential you know

Passages & reports (2)
  • supplemental headwind that you flagged for the fourth quarter of 27. Maybe could you just …
  • fourth quarter 27 headwind and then any updates you may have around um the potential you k…

Speaker 6

D

Passages & reports (1)
  • D

Speaker 3

SDP and

Passages & reports (1)
  • SDP and

Speaker 6

provider tax

Passages & reports (1)
  • provider tax

Speaker 3

headwinds from

Passages & reports (1)
  • headwinds from

Speaker 6

28 and beyond

Passages & reports (1)
  • 28 and beyond

Speaker 3

would be

Passages & reports (1)
  • would be

Speaker 6

would

Passages & reports (1)
  • would

Speaker 3

be helpful. Thanks.

Passages & reports (1)
  • be helpful. Thanks.

Speaker unclear

?Yeah

Passages & reports (1)
  • Yeah

Speaker 2

so I mean as far as the headwinds ?in 28 and beyond ?you know we've been disclosing those estimates in our SEC filings you know really since the passage of OB3, uh, we'll update those, you know, with our our current filing, but they they shouldn't be terribly different from

Passages & reports (5)
  • so I mean as far as the headwinds
  • in
  • 28 and beyond
  • you
  • know we've been disclosing those estimates in our SEC filings you know really since the pa…

Speaker unclear

?um you know what we've been disclosing to date. As far as the 10 million uh

Passages & reports (1)
  • um you know what we've been disclosing to date. As far as the 10 million uh

Speaker 2

specific headwind

Passages & reports (1)
  • specific headwind

Speaker unclear

?in the fourth quarter of of 27, Jason, I don't have that detail in front of me, but you know happy to to discuss that offline at

Passages & reports (1)
  • in the fourth quarter of of 27, Jason, I don't have that detail in front of me, but you kn…

Speaker 2

some

Passages & reports (1)
  • some

Speaker unclear

?point. Okay. Thanks.

Passages & reports (1)
  • point. Okay. Thanks.

Speaker 0

Thank ?you. Well our next question comes from the line of Andrew Mock of Barclays. The line is now

Passages & reports (3)
  • Thank
  • you. Well
  • our next question comes from the line of Andrew Mock of Barclays. The line is now

Speaker unclear

?open.

Passages & reports (1)
  • open.

Speaker 7

Hi, good morning. Just wanted to follow up on the acute dynamics in the quarter. Acute volumes were very strong, but MedSurge mix was negative and weighed on acute pricing. How does the management

Passages & reports (1)
  • Hi, good morning. Just wanted to follow up on the acute dynamics in the quarter. Acute vol…

Speaker unclear

?team internalize this? Are you

Passages & reports (1)
  • team internalize this? Are you

Speaker 7

comfortable trading mix

Passages & reports (1)
  • comfortable trading mix

Speaker unclear

?and price for stronger volumes, or does this lead you to reconsider elements of your strategy? Thanks.

Passages & reports (1)
  • and price for stronger volumes, or does this lead you to reconsider elements of your strat…

Speaker 2

So I mean the answer, Andrew, is th that's not a sort of conscious swap on our part. You know, we didn't make a conscious decision to you know increase volumes, but you know, decrease procedural volumes. Um, most of our medical volumes, honestly, come to the emergency room. So those are patients who come to us. Procedural volumes are tend to be you know more elective.

Um, we have done a lot of things to continue to build on procedural volumes, including investments in technology and things like robotics and things like OR capacity, et cetera. And that's paid off in the service lines that you know we
mentioned earlier. The other issue I think is, and we talked about, I think Mark talked about in his prepared remarks,

Passages & reports (3)
  • So I mean the answer, Andrew, is th that's not a sort of conscious swap on our part. You k…
  • to us. Procedural volumes are tend to be you know more elective. Um, we have done a lot of…
  • mentioned earlier. The other issue I think is, and we talked about, I think Mark talked ab…

Speaker unclear

?you know, we continue to try and

Passages & reports (1)
  • you know, we continue to try and

Speaker 3

increase our outpatient access points. That includes things like FEDs, freestanding emergency departments, it includes physician offices,

Passages & reports (1)
  • increase our outpatient access points. That includes things like FEDs, freestanding emerge…

Speaker 2

all those things are designed to create more referrals into our procedural volumes. Um so, you know, attempting to do that as well. So, you know, I I d y again I I would just sort of emphasize the fact that, you know, we're looking to to do both to grow volumes overall, but also absolutely to grow surgical and procedural volumes to the extent that we can.

We're not making a choice of
?you know medical medical admissions over surgical admissions.

Passages & reports (4)
  • all those things are designed to create more referrals into our procedural volumes. Um so,…
  • absolutely to grow surgical and procedural volumes to the extent that we can. We're not ma…
  • you
  • know medical medical admissions over surgical admissions.

Speaker 7

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Thank ?you. Our next question comes from the line of Ben Hendricks of RBC Capital Markets. Your line is now open.

Passages & reports (3)
  • Thank
  • you.
  • Our next question comes from the line of Ben Hendricks of RBC Capital Markets. Your line i…

Speaker unclear

?Great. Thank you very much.

Passages & reports (1)
  • Great. Thank you very much.

Speaker 3

As we get past the de novo ramp and the talkspace integration, I think you noted that CapEx would normalize down to an 800 million range. It seems like that's getting closer to maintenance levels, but just are there any kind of development priorities you would rank order going forward following the uh the uh integrations and and de novo ramps? I mean, would you be focusing on further build-out of behavioral capabilities versus acute service lines versus tech and AI development?

Kind of what how would you think about your priorities there? Thanks.

Passages & reports (2)
  • As we get past the de novo ramp and the talkspace integration, I think you noted that CapE…
  • integrations and and de novo ramps? I mean, would you be focusing on further build-out of …

Speaker 2

Yeah, so I would just clarify a little bit, Ben, you know, um your comment. So as we go from ?a billion dollars a year roughly that we've been spending on CapEx to 800 million going forward, um, that's largely because these large de novo projects that we've had over the last several years, The Palm Beach Gardens Hospital, the Riverside County, California Replacement Facility, West Henderson.

We don't really have any full-scale de novo projects, and that's largely contributing to the decline. You sort of characterize $800 million as maintenance capital. I think that's a bit of an exaggeration. We we sort of, I think, consider maybe two percent of our revenues uh to be devoted to
maintenance capital. So something in that $250, ?you know, $300 million range. So there's another four, $500, $550 million of expansionary capital in the $800.

Um and that's, you know, new new capacity, new beds, new ORs, new ERs, robotics in in the um in the acute care uh, you know, uh
segment. And uh you know, I think an emphasis on, and we we've touched on this in in other ways in our comments here, you know, an emphasis on outpatient growth and outpatient access access points in both of the segments. ?

So
yeah, I mean I I think the the primary uh driver of the decline is just not having any of these big de novo projects in the pipeline over the next several years. But it certainly doesn't indicate an unwillingness on our part to continue to reinvest in the business in strategically in the areas that we think will will drive growth in the future.

Passages & reports (11)
  • Yeah, so I would just clarify a little bit, Ben, you know, um your comment. So as we go fr…
  • a
  • billion dollars a year roughly that we've been spending on CapEx to 800 million going forw…
  • We don't really have any full-scale de novo projects, and that's largely contributing to t…
  • maintenance capital. So something in that $250,
  • you know,
  • $300 million range. So there's another four, $500, $550 million of expansionary capital in…
  • segment. And uh you know, I think an emphasis on, and we we've touched on this in in other…
  • So
  • yeah, I mean I I think the the primary uh driver of the decline is just not having any of …
  • that we think will will drive growth in the future.

Speaker 0

Thank you. Our next question comes from the line of Scott Fidel, Goldman Sachs. Your line is now

Passages & reports (1)
  • Thank you. Our next question comes from the line of Scott Fidel, Goldman Sachs. Your line …

Speaker unclear

?open. Oh hi, thanks. Good

Passages & reports (1)
  • open. Oh hi, thanks. Good

Speaker 7

morning.

Passages & reports (1)
  • morning.

Speaker 4

First question, just uh appreciate the details that you gave us on the um anticipated um State Director Payments, headwind. Uh would you be able to break that out between uh the mix of that between acute care and behavioral?

Passages & reports (1)
  • First question, just uh appreciate the details that you gave us on the um anticipated um S…

Speaker unclear

?So

Passages & reports (1)
  • So

Speaker 2

Scott, I think what we've said historically is that the SDP payments are

Passages & reports (1)
  • Scott, I think what we've said historically is that the SDP payments are

Speaker 3

split pretty evenly between the two segments.

Passages & reports (1)
  • split pretty evenly between the two segments.

Speaker unclear

?Okay.

Passages & reports (1)
  • Okay.

Speaker 7

And then

Passages & reports (1)
  • And then

Speaker 4

just uh would would be interested in um uh an update on on the health plan, uh the Medicare Advantage plan, um, ?you know, which is getting quite uh you know, you guys have been growing it pretty impressively the last couple of years and it's getting quite sizable. Can you sort of talk about how the uh you know MLR trends of the business have been going this year and then ?in terms of your bids for uh 2027, how you position those relative to growth first margins?

Thanks.

Passages & reports (5)
  • just uh would would be interested in um uh an update on on the health plan, uh the Medicar…
  • you know,
  • which is getting quite uh you know, you guys have been growing it pretty impressively the …
  • in
  • terms of your bids for uh 2027, how you position those relative to growth first margins? T…

Speaker 2

Yeah, so um you described the health plan as an MA plan. It is largely an MA

Passages & reports (1)
  • Yeah, so um you described the health plan as an MA plan. It is largely an MA

Speaker unclear

?plan, about 90% of its revenue comes from MA, but it is it does have about a 10% commercial mix

Passages & reports (1)
  • plan, about 90% of its revenue comes from MA, but it is it does have about a 10% commercia…

Speaker 2

as ?well. Um, you know, we talked about in 2026 a $25 million roughly tailwind from improvements at the health plan, and I think we are largely tracking to that. I think next year there'll be sort of the normal amount of growth as the as the revenue has grown, but not expecting a material impact up or down in terms of our earnings in 2027 as a result of the health plan.

Obviously, the health plan from our perspective continues to provide a significant benefit to our acute care hospitals. We operate the plan only in those markets in which we have acute care
hospitals.

Passages & reports (5)
  • as
  • well.
  • Um, you know, we talked about in 2026 a $25 million roughly tailwind from improvements at …
  • but not expecting a material impact up or down in terms of our earnings in 2027 as a resul…
  • hospitals.

Speaker 4

Steve, can you just on the margins, just uh sort of where you view the the MA pre-tax uh margin now after getting that $25 million uh sort of improvement in the underlying artificial and that's it for me. Thanks.

Passages & reports (1)
  • Steve, can you just on the margins, just uh sort of where you view the the MA pre-tax uh m…

Speaker unclear

?Yeah,

Passages & reports (1)
  • Yeah,

Speaker 2

we think that historically the plan has operated with sort of either low uh negative single-digit margins or low positive single di digit margins. I think the improvement from last year, you know, is because the plan's

Passages & reports (1)
  • we think that historically the plan has operated with sort of either low uh negative singl…

Speaker 1

operating in

Passages & reports (1)
  • operating in

Speaker 2

low positive

Passages & reports (1)
  • low positive

Speaker 1

single digit margins. And I think that's our

Passages & reports (1)
  • single digit margins. And I think that's our

Speaker 2

expectation

Passages & reports (1)
  • expectation

Speaker 1

that that it will

Passages & reports (1)
  • that that it will

Speaker 2

continue to do so uh in

Passages & reports (1)
  • continue to do so uh in

Speaker unclear

?you know

Passages & reports (1)
  • you know

Speaker 1

over the next ?couple of years.

Passages & reports (3)
  • over the next
  • couple
  • of years.

Speaker 0

Thank you. Our next question will come from the line of Benjamin Rossi of JP Morgan. Your line is now open.

Passages & reports (1)
  • Thank you. Our next question will come from the line of Benjamin Rossi of JP Morgan. Your …

Speaker 7

Hey good morning. Thanks for taking my question. ?Uh I've heard you describe a few offset opportunities in recent quarters related to your payer mix initiatives, uh, your outpatient network development across segments, some of your technology investments, and then some of your expense initiatives or things like supplies. I know you aren't providing formal 2027 commentary, but could you walk us through how those initiatives are coming together and where you expect to see contribution and margins in the coming quarters?

Passages & reports (4)
  • Hey good morning. Thanks for taking my question.
  • Uh
  • I've heard you describe a few offset opportunities in recent quarters related to your paye…
  • those initiatives are coming together and where you expect to see contribution and margins…

Speaker 2

Yeah, man, look, I think you've you know done a decent job of framing your question around the things that we have already discussed as we think about the challenges uh that will come, especially from OB3 in ?the next few ?years, whether that's Medicaid work requirements in 27 and 28 or the Medicaid supplemental uh

Passages & reports (5)
  • Yeah, man, look, I think you've you know done a decent job of framing your question around…
  • the
  • next few
  • years, whether that's
  • Medicaid work requirements in 27 and 28 or the Medicaid supplemental uh

Speaker unclear

?you know

Passages & reports (1)
  • you know

Speaker 3

reductions mostly in 28 and beyond. Uh, you know, a number of things that you know we are

Passages & reports (1)
  • reductions mostly in 28 and beyond. Uh, you know, a number of things that you know we are

Speaker unclear

?trying to address.

Passages & reports (1)
  • trying to address.

Speaker 1

Um, technology developments, we've talked

Passages & reports (1)
  • Um, technology developments, we've talked

Speaker 2

in previous quarterly calls about the things that we're doing in revenue cycle to improve revenue cycle performance. We had a very large third party consulting exercise in our acute care revenue cycle in the last several, you know, 18 months or so. We're undergoing a similar exercise in behavioral developing technology, AI and otherwise, to help us do that, developing tech technology, AI and otherwise, to help us control length of stay, better control length of stay in acute care.

I think you alluded to this in your question. A lot of the outpatient emphasis
?in behavioral, whether that's talkspace or thousand branches or just the efforts within our existing facilities, really have the double benefit of meeting demand where patients are looking for it in the outpatient setting, but it also as we build outpatient, we're really shifting our payer mix away from Medicaid and more to commercial and Medicare because that's where that's where we think the growth is and and that helps us avoid some of these Medicaid cuts.

So doing all those things again in terms of their specific impact and their specific impact in twenty twenty seven,
?uh, you know, I think we'll

Passages & reports (7)
  • in previous quarterly calls about the things that we're doing in revenue cycle to improve …
  • behavioral developing technology, AI and otherwise, to help us do that, developing tech te…
  • in
  • behavioral, whether that's talkspace or thousand branches or just the efforts within our e…
  • because that's where that's where we think the growth is and and that helps us avoid some …
  • uh,
  • you know, I think we'll

Speaker 1

provide more color on that uh in February. Stephen, I think we have time for one more question.

Passages & reports (1)
  • provide more color on that uh in February. Stephen, I think we have time for one more ques…

Speaker 0

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Our last question comes from the line of Sarah James of Cantora Fitzgerald. Your line is now open.

Passages & reports (1)
  • Our last question comes from the line of Sarah James of Cantora Fitzgerald. Your line is n…

Speaker 3

Thank you. Um Just a quick clarification on exchanges, and then I have a question on talk. So on the exchanges, when you talked about at least a $15 million headwind year over year, that's just annualizing the second half. So wanted to clarify,

Passages & reports (1)
  • Thank you. Um Just a quick clarification on exchanges, and then I have a question on talk.…

Speaker unclear

?does that mean

Passages & reports (1)
  • does that mean

Speaker 7

that assumes flat exchange

Passages & reports (1)
  • that assumes flat exchange

Speaker unclear

?market size from 26 to 27? Is that what that 15 million is based on? Yeah,

Passages & reports (1)
  • market size from 26 to 27? Is that what that 15 million is based on? Yeah,

Speaker 2

so Sarah, what you know we've said this year is we expected an $85 million negative impact from the reduction exchange coverage.

Passages & reports (1)
  • so Sarah, what you know we've said this year is we expected an $85 million negative impact…

Speaker 1

35 of that was

Passages & reports (1)
  • 35 of that was

Speaker 2

in the first half of the year, 50 was in the second half of the year. We're assuming that at a minimum the 50 is the run rate into next year. So that's a $15 million. That's where the $15 million headwind comes from. And then what we further said is that to the degree that there are further reductions in exchange volumes next year, that could create an incremental headwind, but we really won't know that until some of ?that enrollment ?data becomes you know more widely available.

Passages & reports (6)
  • in the first half of the year, 50 was in the second half of the year. We're assuming that …
  • that there are further reductions in exchange volumes next year, that could create an incr…
  • that
  • enrollment
  • data becomes
  • you know more widely available.

Speaker 3

Got it. And then on talk, what do you need to see in the

Passages & reports (1)
  • Got it. And then on talk, what do you need to see in the

Speaker unclear

?first 12 months, just proof

Passages & reports (1)
  • first 12 months, just proof

Speaker 3

of ?concept wise, to show that ?step down capture is working? In the past, you've referred to currently capturing load amid single digits, and step down possibly reaching double digit over time. So, what is that timeline?

Passages & reports (5)
  • of
  • concept wise, to show
  • that
  • step
  • down capture is working? In the past, you've referred to currently capturing load amid sin…

Speaker unclear

?Is that like a five-year goal, a 10 year goal? How do we think about that growth?

Passages & reports (1)
  • Is that like a five-year goal, a 10 year goal? How do we think about that growth?

Speaker 2

Yeah, so I think um the way it will be reflected will be an increase in outpatient activity at both UHS and at Talkspace. So, you know, today our outpatient visits, I think, in the third quarter grew by about three percent. I think talkspace, just on an organic basis on their own, you know, their their visits or or procedures, you know, or units, you know, increased by five percent.

I think our expectation is that both of those numbers will accelerate as a result of the the merger and and the um
?you know the continued integration of the the two platforms. ?Um and so yeah that that's I think what will provide the proof of concept. I I think as we said earlier, not going to see a ton of that in the first twelve months, ?but beginning I think in you know the next twelve twelve months after that we'll start to see that benefit and I think it will continue to be sustainable for many years beyond

Passages & reports (8)
  • Yeah, so I think um the way it will be reflected will be an increase in outpatient activit…
  • know, their their visits or or procedures, you know, or units, you know, increased by five…
  • you
  • know the continued integration of the the two platforms.
  • Um
  • and so yeah that that's I think what will provide the proof of concept. I I think as we sa…
  • but
  • beginning I think in you know the next twelve twelve months after that we'll start to see …

Speaker unclear

?that.

Passages & reports (1)
  • that.

Speaker 3

Thank

Passages & reports (1)
  • Thank

Speaker unclear

?you.

Passages & reports (1)
  • you.

Speaker 0

Thank you. This concludes the question and answer session. I would now like to turn it back to Darren for closing remarks.

Passages & reports (1)
  • Thank you. This concludes the question and answer session. I would now like to turn it bac…

Speaker 1

Thanks, Stephen, and thank you everyone for participating in today's call and for your interest in UHS. Have a great rest of your

Passages & reports (1)
  • Thanks, Stephen, and thank you everyone for participating in today's call and for your int…

Speaker unclear

?day.

Passages & reports (1)
  • day.

Speaker 0

Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.

Passages & reports (1)
  • Thank you for your participation in today's conference. This does conclude the program. Yo…
Source, accuracy & exportsMay contain errorsAccuracy unmeasured. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred. Speakers are anonymous voice labels, local to this call. No names are verified. Section starts and timestamps are inferred.

Short unclear spans may appear inline between matching voice IDs. The ? marker retains unknown attribution; no voice identity is inferred for those words.

AI-generated transcript; names, numbers and wording may be inaccurate.

Speaker IDs are anonymous and local to this call. Section boundaries and timestamps are inferred.

1 words have zero-duration alignments. Use surrounding audio; no timing has been repaired.

The diarizer reached its eight-speaker limit; distinct voices may share an ID.

Zero-duration alignments: 1. Unassigned words: 625. No alignment has been repaired. Timestamps locate passages in the source recording; decimal positions do not establish word-level precision.

Official issuer source ↗ · Report an issue

Published transcript · Full recording available. Publication updated 2026-11-16T00:43:59.259Z.
Transcript version v1-af58890ccb50b67a257c · publication revision 1. Generated by AI; no listener-verified accuracy score is available.

Dotted spans marked ? have an unclear speaker. They remain unattributed even when shown inside a surrounding turn.

Copy or download
ReadableGrouped by speaker and paragraph with timestamps. Stored words unchanged.
As storedOne line per stored segment with its original speaker ID and start time. Exactly the stored words.
Official issuer source ↗Company overview ↗
TRANSCRIPT FEEDBACK

Report a passage

Your report is queued privately for review. It does not change this transcript automatically. Please avoid personal information.